| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.31 | 1e-11 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.059 | 0.2 |